Patents by Inventor William Rocco

William Rocco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING
    Publication number: 20230322657
    Abstract: Described herein are crystalline forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-in-dene-2-carboxylic acid and methods of making the same. Such forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid are useful in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with an EDG-2 receptor antagonist compound.
    Type: Application
    Filed: August 31, 2021
    Publication date: October 12, 2023
    Inventors: Josef PERNERSTORFER, William ROCCO, Jason BRITTAIN
  • CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING
    Publication number: 20220064105
    Abstract: Described herein are crystalline forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid and methods of making the same. Such forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid are useful in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with an EDG-2 receptor antagonist compound.
    Type: Application
    Filed: August 31, 2021
    Publication date: March 3, 2022
    Inventors: Josef PERNERSTORFER, William ROCCO, Jason BRITTAIN
  • Crystalline form
    Patent number: 7683062
    Abstract: Disclosed are a novel crystalline form of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, processes of preparing said crystalline form of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, compositions comprising said form in admixture with one or more pharmaceutically acceptable excipients, and uses for the same.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: March 23, 2010
    Assignee: sanofi-aventis U.S. LLC
    Inventors: William Rocco, John D. Higgins
  • Solid pharmaceutical dispersions
    Patent number: 5837714
    Abstract: This invention provides solid pharmaceutical dispersions comprising a poorly soluble drug substance, as SR48692 or naproxen, xylitol and Transcutol, and a method of preparing such dispersions comprising the steps of dissolving the poorly soluble drug substance in Transcutol and adding the solution to xylitol. The dispersions exhibit good pharmaceutical properties and reduced levels of impurities and degradation products.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: November 17, 1998
    Assignee: Sanofi
    Inventors: William Rocco, Sharon Laughlin
  • Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
    Patent number: 5656288
    Abstract: Disodium tiludronate tetrahydrate is provided for use in pharmaceutical compositions for oral administration in the form of a tablet, effervescent composition, capsule and the like.
    Type: Grant
    Filed: June 8, 1995
    Date of Patent: August 12, 1997
    Assignee: Sanofi Winthrop, Inc.
    Inventors: William Rocco, Sharon M. Laughlin